Board of Directors of CytoDyn Inc. terminated the employment of Nader Z. Pourhassan, Ph.D. CEO of the Company, effective January 24, 2022. The rest of CytoDyn's executive team is continuing with the Company and is united in their commitment to advance the Company's objectives.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2075 USD | +6.41% | +23.44% | +6.41% |
Apr. 15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 05 | Transcript : CytoDyn Inc. - Special Call |
1st Jan change | Capi. | |
---|---|---|
+6.41% | 194M | |
+8.63% | 115B | |
+13.17% | 107B | |
-12.76% | 22.31B | |
-3.99% | 21.6B | |
-7.19% | 18.23B | |
-39.93% | 17.62B | |
+6.67% | 14.26B | |
+33.90% | 12.37B | |
-28.60% | 8.28B |
- Stock Market
- Equities
- CYDY Stock
- News CytoDyn Inc.
- CytoDyn Announces Executive Changes